DexCom Pre-Tax Profit Margin 2010-2025 | DXCM
Current and historical pre-tax profit margin for DexCom (DXCM) from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. DexCom pre-tax profit margin for the three months ending March 31, 2025 was .
| DexCom Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $4.15B | $0.73B | 17.60% |
| 2024-12-31 | $4.03B | $0.71B | 17.58% |
| 2024-09-30 | $3.95B | $0.74B | 18.82% |
| 2024-06-30 | $3.94B | $0.81B | 20.51% |
| 2024-03-31 | $3.80B | $0.78B | 20.46% |
| 2023-12-31 | $3.62B | $0.71B | 19.60% |
| 2023-09-30 | $3.40B | $0.60B | 17.54% |
| 2023-06-30 | $3.20B | $0.50B | 15.73% |
| 2023-03-31 | $3.02B | $0.42B | 13.86% |
| 2022-12-31 | $2.91B | $0.39B | 13.40% |
| 2022-09-30 | $2.79B | $0.26B | 9.42% |
| 2022-06-30 | $2.67B | $0.23B | 8.57% |
| 2022-03-31 | $2.57B | $0.25B | 9.76% |
| 2021-12-31 | $2.45B | $0.26B | 10.46% |
| 2021-09-30 | $2.32B | $0.40B | 17.42% |
| 2021-06-30 | $2.17B | $0.37B | 16.91% |
| 2021-03-31 | $2.03B | $0.32B | 15.59% |
| 2020-12-31 | $1.93B | $0.30B | 15.41% |
| 2020-09-30 | $1.82B | $0.24B | 13.01% |
| 2020-06-30 | $1.72B | $0.21B | 12.12% |
| 2020-03-31 | $1.60B | $0.15B | 9.56% |
| 2019-12-31 | $1.48B | $0.10B | 7.05% |
| 2019-09-30 | $1.35B | $-0.17B | -12.36% |
| 2019-06-30 | $1.22B | $-0.17B | -13.75% |
| 2019-03-31 | $1.13B | $-0.13B | -11.43% |
| 2018-12-31 | $1.03B | $-0.13B | -12.21% |
| 2018-09-30 | $0.92B | $0.06B | 6.56% |
| 2018-06-30 | $0.83B | $0.01B | 1.44% |
| 2018-03-31 | $0.76B | $-0.03B | -4.20% |
| 2017-12-31 | $0.72B | $-0.05B | -6.68% |
| 2017-09-30 | $0.67B | $-0.06B | -9.57% |
| 2017-06-30 | $0.63B | $-0.08B | -12.64% |
| 2017-03-31 | $0.60B | $-0.09B | -14.36% |
| 2016-12-31 | $0.57B | $-0.07B | -11.34% |
| 2016-09-30 | $0.53B | $-0.06B | -10.51% |
| 2016-06-30 | $0.49B | $-0.08B | -16.36% |
| 2016-03-31 | $0.45B | $-0.06B | -14.38% |
| 2015-12-31 | $0.40B | $-0.06B | -14.43% |
| 2015-09-30 | $0.36B | $-0.06B | -16.62% |
| 2015-06-30 | $0.32B | $-0.02B | -6.58% |
| 2015-03-31 | $0.29B | $-0.02B | -8.07% |
| 2014-12-31 | $0.26B | $-0.02B | -8.88% |
| 2014-09-30 | $0.23B | $-0.03B | -11.89% |
| 2014-06-30 | $0.20B | $-0.03B | -13.93% |
| 2014-03-31 | $0.18B | $-0.03B | -17.98% |
| 2013-12-31 | $0.16B | $-0.03B | -18.63% |
| 2013-09-30 | $0.14B | $-0.04B | -24.65% |
| 2013-06-30 | $0.12B | $-0.05B | -37.70% |
| 2013-03-31 | $0.11B | $-0.05B | -46.79% |
| 2012-12-31 | $0.10B | $-0.06B | -55.56% |
| 2012-09-30 | $0.09B | $-0.06B | -67.05% |
| 2012-06-30 | $0.08B | $-0.06B | -66.27% |
| 2012-03-31 | $0.08B | $-0.05B | -58.02% |
| 2011-12-31 | $0.08B | $-0.04B | -58.67% |
| 2011-09-30 | $0.07B | $-0.04B | -60.87% |
| 2011-06-30 | $0.06B | $-0.04B | -66.67% |
| 2011-03-31 | $0.05B | $-0.05B | -87.04% |
| 2010-12-31 | $0.05B | $-0.06B | -110.00% |
| 2010-09-30 | $0.04B | $-0.06B | -129.55% |
| 2010-06-30 | $0.04B | $-0.06B | -148.72% |
| 2010-03-31 | $0.03B | $-0.06B | -179.41% |
| 2009-12-31 | $0.03B | $-0.05B | -186.21% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $31.765B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $182.611B | 79.98 |
| Thermo Fisher Scientific (TMO) | United States | $148.189B | 17.92 |
| Edwards Lifesciences (EW) | United States | $43.397B | 28.45 |
| Alcon (ALC) | Switzerland | $41.812B | 28.26 |
| IDEXX Laboratories (IDXX) | United States | $41.807B | 48.04 |
| IQVIA Holdings (IQV) | United States | $26.748B | 14.98 |
| Mettler-Toledo (MTD) | United States | $23.806B | 28.31 |
| STERIS (STE) | Ireland | $23.238B | 25.59 |
| Waters (WAT) | United States | $20.195B | 28.49 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.992B | 0.00 |
| Hologic (HOLX) | United States | $14.255B | 15.49 |
| Sysmex ADR (SSMXY) | Japan | $10.670B | 30.27 |
| Penumbra (PEN) | United States | $9.953B | 78.12 |
| Masimo (MASI) | United States | $8.825B | 32.55 |
| Globus Medical (GMED) | United States | $7.767B | 18.51 |
| Glaukos (GKOS) | United States | $5.848B | 0.00 |
| Teleflex (TFX) | United States | $5.202B | 8.59 |
| TransMedics (TMDX) | United States | $4.194B | 91.18 |
| Integer Holdings (ITGR) | United States | $4.151B | 21.75 |
| PROCEPT BioRobotics (PRCT) | United States | $3.301B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.463B | 14.67 |
| Veracyte (VCYT) | United States | $2.100B | 29.47 |
| Nihon Kohden (NHNKY) | Japan | $1.988B | 22.80 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 16.93 |
| Alphatec Holdings (ATEC) | United States | $1.592B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.359B | 0.00 |
| Artivion (AORT) | United States | $1.268B | 118.80 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.012B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.926B | 4.92 |
| Beta Bionics (BBNX) | United States | $0.771B | 0.00 |
| IRadimed (IRMD) | United States | $0.743B | 37.71 |
| SiBone (SIBN) | United States | $0.711B | 0.00 |
| RxSight (RXST) | United States | $0.564B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.559B | 8.69 |
| Mesa Laboratories (MLAB) | United States | $0.507B | 11.89 |
| Delcath Systems (DCTH) | United States | $0.493B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.489B | 0.00 |
| AxoGen (AXGN) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.406B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.356B | 9.48 |
| NeuroPace (NPCE) | United States | $0.348B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.343B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| 908 Devices (MASS) | United States | $0.286B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.03 |
| Neuronetics (STIM) | United States | $0.222B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.221B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.205B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.152B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Accuray (ARAY) | United States | $0.127B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.40 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.39 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |